This department is offering the DoD Peer Reviewed Medical Technology/Therapeutic Development Award to translate preclinical findings into clinical applications for the health care needs of military personnel. The grant supports the development of pharmacologic agents, devices, or clinical guidance in specified topic areas. Applicants must provide a transition plan showing how the product will progress to the next development stage beyond the grant period. Closing date for applications is Oct 17, 2014.
Opportunity ID: 254517
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-PRMRP-TTDA |
| Funding Opportunity Title: | DoD Peer Reviewed Medical Technology/Therapeutic Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 6 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 30, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 17, 2014 |
| Current Closing Date for Applications: | Oct 17, 2014 |
| Archive Date: | Nov 16, 2014 |
| Estimated Total Program Funding: | $13,500,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The PRMRP Technology/Therapeutic Development Award is a product-driven award intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, patient care, and/or quality of life, in at least one of the Congressionally directed FY14 PRMRP Topic Areas. See Program Announcement for Topic Areas. Products in development should be responsive to the health care needs of military service members, Veterans, and/or beneficiaries. The product(s) to be developed may be pharmacologic agents (drugs or biologics), devices, and/or clinical guidance for standard of care. The Principal Investigator (PI) must provide a transition plan (including potential funding and resources) showing how the product will progress to the next level of development (e.g., clinical trials, delivery to the military or civilian market) after the completion of the PRMRP award. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507; help@eBRAP.org
Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 254517 Full Announcement-1 -> fy14 prmrp ttda_gg.pdf
Folder 254517 Full Announcement-2 -> fy14 prmrp ttda_gg_2.pdf
Packages
| Agency Contact Information: | 301-682-5507; help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00195951 | Apr 30, 2014 | Oct 17, 2014 | View |
Package 1
Mandatory forms
254517 RR_SF424_2_0-2.0.pdf
254517 RR_Budget_1_3-1.3.pdf
254517 RR_KeyPersonExpanded_2_0-2.0.pdf
254517 PerformanceSite_2_0-2.0.pdf
Optional forms
254517 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
